ALL-BFM 95 treatment in turkish children with acute lymphoblastic leukemiaexperience of a single center

Pediatric Hematology and Oncology

Volumn 29, Issue 2, 2012, Pages 130-140

  Kocak, Ulker ^a   Gursel, Turkiz ^a   Kaya, Zuhre ^a   Aral, Yusuf Ziya ^a   Albayrak, Meryem ^a   Keskin, Ebru Yiílmaz ^a   Belen, Burcu ^a   Isiík, Melek ^a   Öner, Nergiz ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Acute lymphoblastic leukemia; ALL BFM 95 protocol; Children

Indexed keywords

CYTARABINE; DEXAMETHASONE; IMMUNOGLOBULIN; MERCAPTOPURINE; METHOTREXATE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; CANCER MORTALITY; CHILD; CLINICAL PROTOCOL; COHORT ANALYSIS; DISEASE FREE SURVIVAL; DRUG MEGADOSE; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; SCHOOL CHILD; TURKEY (REPUBLIC);

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RECURRENCE; REMISSION INDUCTION; TREATMENT OUTCOME; TURKEY;

EID: 84857876329     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2011.629859     Document Type: Article

References (26)

1. Schrappe M. Evolution of BFM trials for childhood ALL. Ann Hematol. 2004;83(Suppl 1):S121-S123.
2. Ribeiro R, Pui CH. Treatment of acute lymphoblastic leukemia in low-and middle-income countries: challenges and opportunities. Leuk Lymphoma. 2008;49:373-376. (Pubitemid 351298319)
3. Pui CH. Toward a total cure for acute lymphoblastic leukemia. J Clin Oncol. 2009;27:5121-5123.
4. Möricke A, Reiter A, Zimmermann M, et al., for the German-Austrian-Swiss ALL-BFM Study Group. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95. Blood. 2008;111:4477-4489.
5. Möricke A, Zimmermann M, Reiter A, et al. Long-term results of fve consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000. Leukemia. 2010;24:265-284.
6. Gu LJ, Li J, Xue HL, et al. Clinical outcome of children with newly diagnosed acute lymphoblastic leukemia treated in a single center in Shanghai, China. Leuk Lymphoma. 2008;49:488-494. (Pubitemid 351298332)
7. Karachunskiy A, Herold R, von Stackelberg A, et al. Leukemia. Results of the frst randomized multi-centre trial on childhood acute lymphoblastic leukaemia in Russia. Leukemia. 2008;22:1144-1153. (Pubitemid 351833781)
8. Yetgin S, Cetin M. Te dose related efect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia. Leuk Lymphoma. 2003;44:489-495. (Pubitemid 36113894)
9. Irken G, Oren H, Gulen H, et al. Treatment outcome of adolescents with acute lymphoblastic leukemia. Ann Hematol. 2002;81:641-645. (Pubitemid 36075518)
10. Hazar V, Karasu GT, Uygun V, et al. Childhood acute lymphoblastic leukemia in Turkey: factors infuencing treatment and outcome: a single center experience. J Pediatr Hematol Oncol. 2010;32:e317-e322.
11. Kaya Z, Gursel T, Bakkaloglu SA, et al. Evaluation ofrenalfunction in Turkish children receiving BFM-95 therapy for acute lymphoblastic leukemia. Pediatr Hematol Oncol. 2007;24:257-267. (Pubitemid 47026965)
12. Kaya Z, Gursel T, Kocak U, et al. Invasive fungal infections in pediatric leukemia patients receiving fuconazole prophylaxis. Pediatr Blood Cancer. 2009;52:470-475.
13. Hussein H, Sidhom I, Naga SA, et al. Outcome and prognostic factors of acute lymphoblas-tic leukemia in children at the National Cancer Institute, Egypt. J Pediatr Hematol Oncol. 2004;26:507-514. (Pubitemid 39045468)
14. Bajel A, George B, Mathews V, et al. Treatment of children with acute lymphoblastic leukemia in India using a BFM protocol. Pediatr Blood Cancer. 2008;51:621-625.
15. Attarbaschi A, Mann G, Dworzak M, et al; Austrian Cooperative Study Group. Treatment results of childhood acute lymphoblastic leukemia in Austria-a report of 20 years' experience. Wien Klin Wochenschr. 2002;114:148-157. (Pubitemid 34215334)
16. Aricò M, Valsecchi MG, Rizzari C, et al. Long-term results of the AIEOP-ALL-95 Trial for Childhood Acute Lymphoblastic Leukemia: insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Munster based chemotherapy. J Clin Oncol. 2008;26:283-289.
17. Pui CH, Pei D, Sandlund JT, et al. Long-term results of St Jude Total Terapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia. 2010;24:371-382.
18. Nachman JB, La MK, Hunger SP, et al. Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and beneft from intensive postinduction treatment: a report from the children's oncology group. J Clin Oncol. 2009;27:5189-5194.
19. Moghrabi A, Levy DE, Asselin B, et al. Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood. 2007;109:896-904. (Pubitemid 46220632)
20. Mitchell C, Richards S, Harrison CJ, Eden T. Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980-2001. Leukemia. 2010;24:406-418.
21. Laks D, Longhi F, Wagner MB, Garcia PC. Survival evaluation of children with acute lymphoblastic leukemia treated with Berlin-Frankfurt-Munich trial. J Pediatr (Rio J). 2003;79:149-158. (Pubitemid 36604441)
22. Sackmann-Muriel F, Felice MS, Zubizarreta PA, et al. Treatment results in childhood acute lym-phoblastic leukemia with a modifed ALL-BFM'90 protocol: lack of improvement in high-risk group. Leuk Res. 1999;23:331-340. (Pubitemid 29166766)
23. Buendia MT, Lozano JM, Suarez GE, et al. Te impact of acute lymphoblastic leukemia treatment on central nervous system results in Bogota, Colombia. J Pediatr Hematol Oncol. 2008;30:643-650.
24. Gao YJ, Lu FJ, Wang HS. Treating childhood acute lymphoblastic leukemia in a developing country 1998-2003: the experience of a single children's hospital in China. Pediatr Hematol Oncol. 2006;28:798-802.
25. Bonilla M, Moreno N, Marina N, et al. Acute lymphoblastic leukemia in a developing country: preliminary results of a nonrandomized clinical trial in El Salvador. J Pediatr Hematol Oncol. 2000;22:495-501.
26. Magrath I, Shanta V, Advani S, et al. Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period. Eur J Cancer. 2005;41:1570-1583. (Pubitemid 40981839)